BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37082049)

  • 1. Quantification of inflammatory, angiogenic, and fibrous components of reactive oral lesions with an insight into the pathogenesis.
    Vasanthi V; Divya B; Ramadoss R; Deena P; Annasamy RK; Rajkumar K
    J Oral Maxillofac Pathol; 2022; 26(4):600. PubMed ID: 37082049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Insights for Consummate Diagnosis and Management of Oral Submucous Fibrosis Using Reactive and Reparative Fibrotic Parameter Derived Algorithm.
    Ramadoss R; Krishnan R; Vasanthi V; Bose D; Vijayalakshmi R; Padmanabhan R; Subramanian B
    J Pharm Bioallied Sci; 2021 Jun; 13(Suppl 1):S323-S332. PubMed ID: 34447103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Study of Mast Cell Count in Oral Reactive Lesions and Its Association with Inflammation.
    Kadeh H; Derakhshanfar G; Saravani S
    Turk Patoloji Derg; 2016; 32(1):22-6. PubMed ID: 26832178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of reactive hyperplastic lesions in the oral cavity: a 10 year retrospective study in Santa Catarina, Brazil.
    Dutra KL; Longo L; Grando LJ; Rivero ERC
    Braz J Otorhinolaryngol; 2019; 85(4):399-407. PubMed ID: 29705120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive localised inflammatory hyperplasia of the oral mucosa.
    Awange DO; Wakoli KA; Onyango JF; Chindia ML; Dimba EO; Guthua SW
    East Afr Med J; 2009 Feb; 86(2):79-82. PubMed ID: 19894472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of distribution of reactive localised hyperplasia of the oral cavity in patients at a tertiary health institution in Nigeria.
    Soyele OO; Ladeji AM; Adebiyi KE; Adesina OM; Aborisade AO; Olatunji AS; Adeola HA
    Afr Health Sci; 2019 Mar; 19(1):1687-1694. PubMed ID: 31148999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of mast cell counts and microvessel density in reactive lesions of the oral cavity.
    Kouhsoltani M; Moradzadeh Khiavi M; Tahamtan S
    J Dent Res Dent Clin Dent Prospects; 2016; 10(4):241-246. PubMed ID: 28096950
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation and Comparison of the Biopathology of Collagen and Inflammation in the Extracellular Matrix of Oral Epithelial Dysplasias and Inflammatory Fibrous Hyperplasia Using Picrosirius Red Stain and Polarising Microscopy: A Preliminary Study.
    Varghese SS; Sarojini SB; George GB; Vinod S; Mathew P; Babu A; Sebastian J
    J Cancer Prev; 2015 Dec; 20(4):275-80. PubMed ID: 26734590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of mast cells in oral reactive lesions - an immunohistochemical study.
    Baddireddy SM; Akula ST; Nagilla J; Manyam R
    Acta Biomed; 2022 Oct; 93(5):e2022219. PubMed ID: 36300240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cells and its relation to collagen and VEGF in oral inflammatory lesions.
    Correia KV; Gonzalez AC; Viena CS; Wanderley FG; DE Almeida Reis SR; Medrado AR
    Minerva Stomatol; 2016 Jun; 65(3):144-51. PubMed ID: 27075371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of reactive gingival lesions of oral cavity: A histopathological study.
    Hunasgi S; Koneru A; Vanishree M; Manvikar V
    J Oral Maxillofac Pathol; 2017; 21(1):180. PubMed ID: 28479713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of Vascular and Inflammatory Index in Oral Pyogenic Granuloma and Periapical Granuloma - An Insight into Pathogenesis.
    Vara JT; Gurudu VS; Ananthaneni A; Bagalad BS; Kuberappa PH; Ponnapalli HP
    J Clin Diagn Res; 2017 May; 11(5):ZC25-ZC28. PubMed ID: 28658902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cell count in oral reactive lesions: A histochemical study.
    Reddy V; Bhagwath SS; Reddy M
    Dent Res J (Isfahan); 2014 Mar; 11(2):187-92. PubMed ID: 24932188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive lesions of oral cavity: A survey of 100 cases in Eluru, West Godavari district.
    Kashyap B; Reddy PS; Nalini P
    Contemp Clin Dent; 2012 Jul; 3(3):294-7. PubMed ID: 23293484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin expression and clinicopathologic correlation of oral hyperplastic reactive lesions: An institutional 6-year retrospective study.
    Narwal A; Bala S
    J Oral Maxillofac Pathol; 2017; 21(3):382-386. PubMed ID: 29391712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive lesions of the oral cavity: A retrospective study on 2068 cases.
    Naderi NJ; Eshghyar N; Esfehanian H
    Dent Res J (Isfahan); 2012 May; 9(3):251-5. PubMed ID: 23087727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histochemical and immunohistochemical localisation of elastic system fibres in focal reactive overgrowths of oral mucosa.
    Mighell AJ; Robinson PA; Hume WJ
    J Oral Pathol Med; 1997 Apr; 26(4):153-8. PubMed ID: 9176788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunolocalisation of tenascin-C in focal reactive overgrowths of oral mucosa.
    Mighell AJ; Robinson PA; Hume WJ
    J Oral Pathol Med; 1996 Apr; 25(4):163-9. PubMed ID: 8809684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staining efficacy assessment of a differential routine and special stains for pathological stromal calcifications in maxillofacial lesions.
    Shefali ; Sethi A; Tandon A; Shetty DC; Juneja S
    J Histotechnol; 2020 Sep; 43(3):118-124. PubMed ID: 32156221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of macrophages and eosinophils in reactive lesions of the oral cavity.
    Aghbali AA; Akbarzadeh A; Kouhsoltani M
    J Oral Maxillofac Pathol; 2018; 22(1):147. PubMed ID: 29731578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.